Janine N Copp Selected Research

SN35539

1/2016

Rational design of an AKR1C3-resistant analog of PR-104 for enzyme-prodrug therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Janine N Copp Research Topics

Disease

6	Neoplasms (Cancer) 02/2022 - 04/2013
3	Hypoxia (Hypoxemia) 02/2022 - 08/2013
2	Disease Progression 03/2017 - 10/2015
1	Abscess 01/2020
1	Infections 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Carcinoma (Carcinomatosis) 04/2013

Drug/Important Bio-Agent (IBA)

7	ProdrugsIBA 02/2022 - 04/2013
5	NitroreductasesIBA 02/2022 - 04/2013
5	EnzymesIBA 01/2019 - 04/2013
2	Phosphates (Orthophosphate)IBA 02/2022 - 01/2016
2	PR-104AIBA 02/2022 - 08/2013
1	Colistin (Coly-Mycin)FDA Link 01/2020
1	salicylanilideIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Niclosamide FDA Link 01/2020
1	SN33623IBA 01/2019
1	4-nitroimidazoleIBA 01/2019
1	azomycinIBA 01/2019
1	SN35539IBA 01/2016
1	PR-104IBA 01/2016
1	SN34507IBA 01/2016
1	Oxygen (Dioxygen)IBA 08/2013
1	Proteins (Proteins, Gene)FDA Link 04/2013

Therapy/Procedure

5	Therapeutics 01/2020 - 04/2013